来源:智通财经网
智通财经APP获悉,6月15日(周二)美股盘前,截至北京时间16:09,诺瓦瓦克斯医药(NVAX.US)涨3.27%,报214.51美元。公司新冠候选疫苗针对中度和重度新冠肺炎的保护率为100%,整体有效率为90%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.